THE NET ALLIANCE

RAISING AWARENESS AND EXPANDING NET SUPPORT

The NET Alliance is an initiative from Novartis Oncology dedicated to helping improve outcomes in patients with neuroendocrine tumors (NET). It is a long-term commitment to help patients by working with health care providers to advance the diagnosis and support of NET and to educate patients about their disease.

The NET Alliance aims to help patients

  • Become better advocates for their care
  • Connect with other patients via advocacy groups
  • Have meaningful conversations with their oncologists and other members of their health care team